Ten-year trends in lipid management among patients after myocardial infarction in South Korea
Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and...
Saved in:
Published in | PloS one Vol. 19; no. 10; p. e0304710 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
03.10.2024
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
ISSN | 1932-6203 1932-6203 |
DOI | 10.1371/journal.pone.0304710 |
Cover
Abstract | Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population.
The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased.
The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events. |
---|---|
AbstractList | Background Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population. Methods and findings The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased. Conclusions The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events. BackgroundDyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population.Methods and findingsThe study used a merged database of two nationwide observational cohorts (2011–2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target).The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased.ConclusionsThe adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events. Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population. The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events. Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population.BACKGROUNDDyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population.The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased.METHODS AND FINDINGSThe study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased.The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.CONCLUSIONSThe adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events. Background Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population. Methods and findings The study used a merged database of two nationwide observational cohorts (2011–2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased. Conclusions The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events. Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population. The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased. The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events. |
Audience | Academic |
Author | Kim, Weon Hong, Young Joon Shin, Min-Ho Jeong, Myung Ho Kim, Min Chul Sim, Doo Sun Cho, Kyung Hoon Ahn, Youngkeun Kim, Ju Han Lee, Sang Yeub Oh, Seok |
AuthorAffiliation | 6 Department of Cardiology, Gwangju Veterans Hospital, Gwangju, Republic of Korea 1 Department of Cardiology, Chonnam National University Hospital, Gwangju, Republic of Korea 3 Chung-Ang University Gwangmyeong Hospital and Department of Internal Medicine, Division of Cardiology, Chung-Ang University College of Medicine, Gwangmyeong, Republic of Korea 5 Department of Internal Medicine, Division of Cardiology, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea 2 Department of Cardiology, Chonnam National University Medical School, Gwangju, Republic of Korea 4 Department of Preventive Medicine, Chonnam National University Medical School, Hwasun, Republic of Korea Baylor Scott and White, Texas A&M College of Medicine, UNITED STATES |
AuthorAffiliation_xml | – name: Baylor Scott and White, Texas A&M College of Medicine, UNITED STATES – name: 5 Department of Internal Medicine, Division of Cardiology, Kyung Hee University Hospital, Kyung Hee University, Seoul, Republic of Korea – name: 3 Chung-Ang University Gwangmyeong Hospital and Department of Internal Medicine, Division of Cardiology, Chung-Ang University College of Medicine, Gwangmyeong, Republic of Korea – name: 1 Department of Cardiology, Chonnam National University Hospital, Gwangju, Republic of Korea – name: 4 Department of Preventive Medicine, Chonnam National University Medical School, Hwasun, Republic of Korea – name: 2 Department of Cardiology, Chonnam National University Medical School, Gwangju, Republic of Korea – name: 6 Department of Cardiology, Gwangju Veterans Hospital, Gwangju, Republic of Korea |
Author_xml | – sequence: 1 givenname: Seok orcidid: 0000-0002-6193-2982 surname: Oh fullname: Oh, Seok – sequence: 2 givenname: Kyung Hoon orcidid: 0000-0002-0377-6352 surname: Cho fullname: Cho, Kyung Hoon – sequence: 3 givenname: Min Chul surname: Kim fullname: Kim, Min Chul – sequence: 4 givenname: Doo Sun surname: Sim fullname: Sim, Doo Sun – sequence: 5 givenname: Young Joon surname: Hong fullname: Hong, Young Joon – sequence: 6 givenname: Ju Han orcidid: 0000-0002-3186-0770 surname: Kim fullname: Kim, Ju Han – sequence: 7 givenname: Youngkeun surname: Ahn fullname: Ahn, Youngkeun – sequence: 8 givenname: Sang Yeub surname: Lee fullname: Lee, Sang Yeub – sequence: 9 givenname: Min-Ho surname: Shin fullname: Shin, Min-Ho – sequence: 10 givenname: Weon orcidid: 0000-0003-1264-9870 surname: Kim fullname: Kim, Weon – sequence: 11 givenname: Myung Ho surname: Jeong fullname: Jeong, Myung Ho |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39361921$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk1uL1DAUx4usuBf9BqIFQfRhxtx6yZMsi5fBhQV39U3CaZp0srTJmKTifHszTneZyj5IH9qc_M4_Pf-cc5odWWdVlj3HaIlphd_dutFb6JebFF4iiliF0aPsBHNKFiVB9Ojg-zg7DeEWoYLWZfkkO6aclpgTfJL9uFF2sVXg8-iVbUNubN6bjWnzASx0alA25jA42-UbiCatQg46Kp8PWyfBtwb6lKPBy2ic3aVfuzGu8y_OK3iaPdbQB_Vsep9l3z5-uLn4vLi8-rS6OL9cyJKRuGg0A05bVmOQpEW8xTVBmFdcStCUMV6AbhBo1eK2LihuCNKgcaN0XUiJJD3LXu51N70LYnImCIoxqTjFpEjEak-0Dm7FxpsB_FY4MOJvwPlOgI9G9kog3MhKpyzOEZOMAiMNKokuGp1s4yRpvZ9OG5tBtTKZ4qGfic53rFmLzv0SGKdaWM2TwptJwbufowpRDCZI1fdglRv3P14XVVXihL76B324vInqIFWQ7sOlg-VOVJzXGKOSlRQlavkAlZ5WDUamPtImxWcJb2cJiYnqd-xgDEGsrr_-P3v1fc6-PmDXCvq4Dq4fdy0U5uCLQ6vvPb5r4ASwPSC9C8ErfY9gJHZzcmeX2M2JmOaE_gHd_APx |
Cites_doi | 10.1038/s41569-021-00541-4 10.1001/jama.290.16.2174 10.1136/bmj.316.7134.838 10.1001/jamacardio.2019.0911 10.1186/s12944-019-1080-x 10.1161/CIRCOUTCOMES.121.008861 10.1056/NEJMoa040583 10.1016/j.jcin.2012.05.009 10.1186/s12944-019-1158-5 10.1093/eurheartj/ehw272 10.1016/S0140-6736(18)32225-6 10.1177/0020715206070267 10.1097/MED.0b013e3283444b09 10.1093/eurheartj/ehz455 10.1177/1741826711422764 10.4070/kcj.2020.0196 10.3390/jcm12093187 10.3349/ymj.2021.62.5.400 10.1177/2040622316672544 10.12997/jla.2023.12.1.12 10.12997/jla.2021.10.2.202 10.1016/j.jacc.2022.07.006 10.3346/jkms.2021.36.e259 10.1016/j.jacl.2023.09.013 10.1016/j.amjcard.2005.03.069 10.1253/circj.CJ-16-0061 10.1016/j.jacl.2022.05.002 10.1056/NEJMoa1410489 10.3390/jcm11061593 10.1371/journal.pone.0152207 10.3904/kjim.2021.204 10.1016/j.jacc.2018.11.003 10.1016/j.jacc.2013.11.002 10.3904/kjim.2018.312 10.1016/j.cpcardiol.2021.101068 10.1161/01.CIR.0000027560.41358.B3 10.1001/jamacardio.2016.4052 10.3346/jkms.2023.38.e419 10.3904/kjim.2018.381 10.3389/fcvm.2021.789931 10.1016/j.jacc.2020.03.033 10.12997/jla.2019.8.2.204 10.1186/s12872-023-03231-w |
ContentType | Journal Article |
Copyright | Copyright: © 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2024 Public Library of Science 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 Oh et al 2024 Oh et al 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Copyright: © 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2024 Public Library of Science – notice: 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 Oh et al 2024 Oh et al – notice: 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0304710 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Agricultural Science Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
DocumentTitleAlternate | Trends in lipid management after AMI in South Korea |
EISSN | 1932-6203 |
ExternalDocumentID | 3112793125 oai_doaj_org_article_01bc7f3129904c43a42b062f5bf93692 PMC11449489 A811064630 39361921 10_1371_journal_pone_0304710 |
Genre | Journal Article Observational Study |
GeographicLocations | Republic of Korea South Korea United States--US |
GeographicLocations_xml | – name: Republic of Korea – name: South Korea – name: United States--US |
GrantInformation_xml | – fundername: ; grantid: HC21C0077 |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM ADRAZ BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 ESTFP PUEGO 5PM |
ID | FETCH-LOGICAL-c642t-bf4a93d481ac2d09d18201979ccaf34495afb0afed1d8531b20faf1bef85cc0c3 |
IEDL.DBID | M48 |
ISSN | 1932-6203 |
IngestDate | Sat Jan 04 00:50:55 EST 2025 Wed Aug 27 01:25:10 EDT 2025 Thu Aug 21 18:35:02 EDT 2025 Mon Sep 08 14:31:54 EDT 2025 Fri Jul 25 10:18:31 EDT 2025 Tue Jun 17 22:03:56 EDT 2025 Tue Jun 10 21:02:57 EDT 2025 Fri Jun 27 05:27:31 EDT 2025 Fri Jun 27 05:27:55 EDT 2025 Thu May 22 21:27:29 EDT 2025 Thu Apr 03 07:06:31 EDT 2025 Tue Jul 01 03:45:29 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | Copyright: © 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c642t-bf4a93d481ac2d09d18201979ccaf34495afb0afed1d8531b20faf1bef85cc0c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 Competing Interests: The authors have declared that no competing interests exist. |
ORCID | 0000-0002-0377-6352 0000-0002-6193-2982 0000-0003-1264-9870 0000-0002-3186-0770 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0304710 |
PMID | 39361921 |
PQID | 3112793125 |
PQPubID | 1436336 |
PageCount | e0304710 |
ParticipantIDs | plos_journals_3112793125 doaj_primary_oai_doaj_org_article_01bc7f3129904c43a42b062f5bf93692 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11449489 proquest_miscellaneous_3112857761 proquest_journals_3112793125 gale_infotracmisc_A811064630 gale_infotracacademiconefile_A811064630 gale_incontextgauss_ISR_A811064630 gale_incontextgauss_IOV_A811064630 gale_healthsolutions_A811064630 pubmed_primary_39361921 crossref_primary_10_1371_journal_pone_0304710 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-10-03 |
PublicationDateYYYYMMDD | 2024-10-03 |
PublicationDate_xml | – month: 10 year: 2024 text: 2024-10-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2024 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | SM Grundy (pone.0304710.ref009) 2019; 4 C Bähler (pone.0304710.ref019) 2012; 19 AL Catapano (pone.0304710.ref016) 2016; 37 SY Lee (pone.0304710.ref043) 2023; 38 F Mach (pone.0304710.ref010) 2020; 41 CP Cannon (pone.0304710.ref013) 2020; 75 NJ Stone (pone.0304710.ref030) 2014; 63 A Pirillo (pone.0304710.ref006) 2021; 18 SY Choi (pone.0304710.ref012) 2020; 35 Y Kim (pone.0304710.ref014) 2019; 34 A Halkin (pone.0304710.ref023) 2005; 96 SM Grundy (pone.0304710.ref008) 2019; 139 SMJ Cho (pone.0304710.ref007) 2021; 10 X Su (pone.0304710.ref011) 2019; 18 S Talic (pone.0304710.ref037) 2022; 47 S Oh (pone.0304710.ref026) 2022; 11 F Rodriguez (pone.0304710.ref028) 2017; 2 JH Kim (pone.0304710.ref015) 2016; 80 UN Khot (pone.0304710.ref024) 2003; 290 CP Cannon (pone.0304710.ref027) 2004; 350 V Barrios (pone.0304710.ref040) 2023; 12 RH Mehta (pone.0304710.ref005) 1998; 316 HK Kim (pone.0304710.ref025) 2020; 50 SM Grundy (pone.0304710.ref029) 2019; 73 CP Cannon (pone.0304710.ref035) 2015; 372 C Marquina (pone.0304710.ref038) 2022; 16 N Salari (pone.0304710.ref003) 2023; 23 KH Cho (pone.0304710.ref001) 2021; 36 DM Lloyd-Jones (pone.0304710.ref017) 2022; 80 X Han (pone.0304710.ref021) 2021; 62 G. Boden (pone.0304710.ref020) 2011; 18 S Oh (pone.0304710.ref004) 2022; 37 AR Zheutlin (pone.0304710.ref042) 2022; 15 C Bardolia (pone.0304710.ref033) 2021; 8 YS Yang (pone.0304710.ref036) 2023; 12 JD Stanaway (pone.0304710.ref002) 2018; 392 FC Pampel (pone.0304710.ref018) 2006; 47 KH Han (pone.0304710.ref031) 2019; 8 T Nakano (pone.0304710.ref034) 2016; 11 M Kayıkcioglu (pone.0304710.ref041) 2023; 17 KY Chen (pone.0304710.ref044) 2012; 5 J Al Suwaidi (pone.0304710.ref022) 2002; 106 D Hammersley (pone.0304710.ref032) 2017; 8 YS Yang (pone.0304710.ref039) 2020; 19 |
References_xml | – volume: 18 start-page: 689 year: 2021 ident: pone.0304710.ref006 article-title: Global epidemiology of dyslipidaemias. publication-title: Nat Rev Cardiol doi: 10.1038/s41569-021-00541-4 – volume: 290 start-page: 2174 year: 2003 ident: pone.0304710.ref024 article-title: Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification publication-title: JAMA doi: 10.1001/jama.290.16.2174 – volume: 316 start-page: 838 year: 1998 ident: pone.0304710.ref005 article-title: Secondary prevention in acute myocardial infarction publication-title: BMJ doi: 10.1136/bmj.316.7134.838 – volume: 4 start-page: 589 year: 2019 ident: pone.0304710.ref009 article-title: 2018 American Heart Association/American College of Cardiology/Multisociety guideline on the management of blood cholesterol-secondary prevention publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2019.0911 – volume: 18 start-page: 134 year: 2019 ident: pone.0304710.ref011 article-title: Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol publication-title: Lipids Health Dis doi: 10.1186/s12944-019-1080-x – volume: 15 start-page: e008861 year: 2022 ident: pone.0304710.ref042 article-title: Lipid-lowering therapy use and intensification among United States veterans following myocardial infarction or coronary revascularization between 2015 and 2019. publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.121.008861 – volume: 350 start-page: 1495 year: 2004 ident: pone.0304710.ref027 article-title: Intensive versus moderate lipid lowering with statins after acute coronary syndromes publication-title: N Engl J Med doi: 10.1056/NEJMoa040583 – volume: 5 start-page: 936 year: 2012 ident: pone.0304710.ref044 article-title: Unrestricted use of 2 new-generation drug-eluting stents in patients with acute myocardial infarction: a propensity score-matched analysis. publication-title: JACC Cardiovasc Interv. doi: 10.1016/j.jcin.2012.05.009 – volume: 19 start-page: 5 year: 2020 ident: pone.0304710.ref039 article-title: Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study publication-title: Lipids Health Dis doi: 10.1186/s12944-019-1158-5 – volume: 37 start-page: 2999 year: 2016 ident: pone.0304710.ref016 article-title: 2016 ESC/EAS guidelines for the management of dyslipidaemias publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw272 – volume: 392 start-page: 1923 year: 2018 ident: pone.0304710.ref002 article-title: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet doi: 10.1016/S0140-6736(18)32225-6 – volume: 47 start-page: 466 year: 2006 ident: pone.0304710.ref018 article-title: Global patterns and determinants of sex differences in smoking. publication-title: Int J Comp Sociol doi: 10.1177/0020715206070267 – volume: 18 start-page: 139 year: 2011 ident: pone.0304710.ref020 article-title: Obesity, insulin resistance and free fatty acids publication-title: Curr Opin Endocrinol Diabetes Obes doi: 10.1097/MED.0b013e3283444b09 – volume: 41 start-page: 111 year: 2020 ident: pone.0304710.ref010 article-title: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz455 – volume: 19 start-page: 1184 year: 2012 ident: pone.0304710.ref019 article-title: Lower age at first myocardial infarction in female compared to male smokers. publication-title: Eur J Prev Cardiol doi: 10.1177/1741826711422764 – volume: 50 start-page: 845 year: 2020 ident: pone.0304710.ref025 article-title: 2020 Korean Society of Myocardial Infarction expert consensus document on pharmacotherapy for acute myocardial infarction publication-title: Korean Circ J doi: 10.4070/kcj.2020.0196 – volume: 12 start-page: 3187 year: 2023 ident: pone.0304710.ref040 article-title: Real-world attainment of low-density lipoprotein cholesterol goals in patients at high risk of cardiovascular disease treated with high-intensity statins: the TERESA study. publication-title: J Clin Med doi: 10.3390/jcm12093187 – volume: 62 start-page: 400 year: 2021 ident: pone.0304710.ref021 article-title: Higher long-term mortality in patients with non-ST-elevation myocardial infarction than ST-elevation myocardial infarction after discharge. publication-title: Yonsei Med J doi: 10.3349/ymj.2021.62.5.400 – volume: 8 start-page: 4 year: 2017 ident: pone.0304710.ref032 article-title: Ezetimibe: an update on its clinical usefulness in specific patient groups. publication-title: Ther Adv Chronic Dis doi: 10.1177/2040622316672544 – volume: 12 start-page: 12 year: 2023 ident: pone.0304710.ref036 article-title: Lipid Management in Korean people with type 2 diabetes mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis consensus statement publication-title: J Lipid Atheroscler doi: 10.12997/jla.2023.12.1.12 – volume: 10 start-page: 202 year: 2021 ident: pone.0304710.ref007 article-title: Dyslipidemia Fact Sheets in Korea 2020: an analysis of nationwide population-based data. publication-title: J Lipid Atheroscler. doi: 10.12997/jla.2021.10.2.202 – volume: 80 start-page: 1366 year: 2022 ident: pone.0304710.ref017 article-title: 2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2022.07.006 – volume: 36 start-page: e259 year: 2021 ident: pone.0304710.ref001 article-title: Preclinical evaluation of a novel polymer-free everolimus-eluting stent in a mid-term porcine coronary restenosis model. publication-title: J Korean Med Sci doi: 10.3346/jkms.2021.36.e259 – volume: 139 start-page: e1082 year: 2019 ident: pone.0304710.ref008 article-title: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines publication-title: Circulation – volume: 17 start-page: 732 year: 2023 ident: pone.0304710.ref041 article-title: Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry. publication-title: J Clin Lipidol doi: 10.1016/j.jacl.2023.09.013 – volume: 96 start-page: 325 year: 2005 ident: pone.0304710.ref023 article-title: Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction. publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2005.03.069 – volume: 80 start-page: 1427 year: 2016 ident: pone.0304710.ref015 article-title: Multicenter cohort study of acute myocardial infarction in Korea–Interim analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry–. publication-title: Circ J doi: 10.1253/circj.CJ-16-0061 – volume: 16 start-page: 498 year: 2022 ident: pone.0304710.ref038 article-title: Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care. publication-title: J Clin Lipidol. doi: 10.1016/j.jacl.2022.05.002 – volume: 372 start-page: 2387 year: 2015 ident: pone.0304710.ref035 article-title: Ezetimibe added to statin therapy after acute coronary syndromes publication-title: N Engl J Med doi: 10.1056/NEJMoa1410489 – volume: 11 start-page: 1593 year: 2022 ident: pone.0304710.ref026 article-title: Outcomes of nonagenarians with acute myocardial infarction with or without coronary intervention. publication-title: J Clin Med doi: 10.3390/jcm11061593 – volume: 11 start-page: e0152207 year: 2016 ident: pone.0304710.ref034 article-title: Ezetimibe promotes brush border membrane-to-lumen cholesterol efflux in the small intestine. publication-title: PLoS One doi: 10.1371/journal.pone.0152207 – volume: 37 start-page: 605 year: 2022 ident: pone.0304710.ref004 article-title: Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time publication-title: Korean J Intern Med doi: 10.3904/kjim.2021.204 – volume: 73 start-page: e285 year: 2019 ident: pone.0304710.ref029 article-title: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.11.003 – volume: 63 start-page: 2889 year: 2014 ident: pone.0304710.ref030 article-title: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.11.002 – volume: 35 start-page: 593 year: 2020 ident: pone.0304710.ref012 article-title: Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases publication-title: Korean J Intern Med doi: 10.3904/kjim.2018.312 – volume: 47 start-page: 101068 year: 2022 ident: pone.0304710.ref037 article-title: Attainment of low-density lipoprotein cholesterol goals in statin treated patients: Real-world evidence from Australia. publication-title: Curr Probl Cardiol. doi: 10.1016/j.cpcardiol.2021.101068 – volume: 106 start-page: 974 year: 2002 ident: pone.0304710.ref022 article-title: Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes publication-title: Circulation doi: 10.1161/01.CIR.0000027560.41358.B3 – volume: 2 start-page: 47 year: 2017 ident: pone.0304710.ref028 article-title: Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2016.4052 – volume: 38 start-page: e419 year: 2023 ident: pone.0304710.ref043 article-title: Significant gap between guidelines and practice in the management of LDL cholesterol: insight from the survey of the Korean Society of Myocardial Infarction. publication-title: J Korean Med Sci doi: 10.3346/jkms.2023.38.e419 – volume: 34 start-page: 1 year: 2019 ident: pone.0304710.ref014 article-title: Current status of acute myocardial infarction in Korea. publication-title: Korean J Intern Med doi: 10.3904/kjim.2018.381 – volume: 8 start-page: 789931 year: 2021 ident: pone.0304710.ref033 article-title: Emerging non-statin treatment options for lowering low-density lipoprotein cholesterol. publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2021.789931 – volume: 75 start-page: 2119 year: 2020 ident: pone.0304710.ref013 article-title: Low-density lipoprotein cholesterol: lower is totally better publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.03.033 – volume: 8 start-page: 204 year: 2019 ident: pone.0304710.ref031 article-title: Should we intensify statin management in ACS patients with very low LDL cholesterol levels? publication-title: J Lipid Atheroscler doi: 10.12997/jla.2019.8.2.204 – volume: 23 start-page: 206 year: 2023 ident: pone.0304710.ref003 article-title: The global prevalence of myocardial infarction: a systematic review and meta-analysis publication-title: BMC Cardiovasc Disord doi: 10.1186/s12872-023-03231-w |
SSID | ssj0053866 |
Score | 2.463163 |
Snippet | Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean... Background Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for... BackgroundDyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for... Background Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for... |
SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e0304710 |
SubjectTerms | Aged Biology and Life Sciences Blood lipids Cardiac patients Cardiology Cardiovascular disease Care and treatment Cholesterol Cholesterol, LDL - blood Clinical outcomes Coronary vessels Demographics Drugs Dyslipidemia Dyslipidemias - drug therapy Dyslipidemias - epidemiology Evaluation Ezetimibe - therapeutic use Female Heart attack Heart attacks Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Ischemia Lipids Low density lipoprotein Low density lipoproteins Male Management Medical research Medicine and Health Sciences Medicine, Experimental Metabolic disorders Middle Aged Mortality Myocardial infarction Myocardial Infarction - drug therapy Myocardial Infarction - epidemiology Patient monitoring Patient outcomes Population studies Prescribing Prescriptions Prevalence Republic of Korea - epidemiology Review boards Risk Factors Risk reduction Statins Trends Vein & artery diseases |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBthiEBBzSxrHzOhZEVUCABC3qBVl2bJeVtsmK7B7675mxvdEGVYID0p7icTY779mMvyHkhVIa6g7DUwWGlApbu7TmpU6VLQR8Cm38_x2fPpen5-LDRXGxNeoLe8ICPHBg3FHGdFs5ztBtilZwJXKdlbkrtMNZdN77Zk22KaaCDwYrLst4UI5X7CjK5XDZd_YQXwZWeGJ2KxB5vP7RK8-Wi364KeX8s3NyKxSd3CV3Yg5Jj8Oz75BbtrtHdqKVDvRVhJJ-fZ_8OLNdeg3KTFe-95XOO7qYL-eGXo1tL9TPG6IRYHWgfmo4vbqGIIfKs4A9DqwBBYjb_cw9-rGHZPMBOT95d_b2NI0DFdIWyoxVqp1QDTeiZqrNTdYYRG9nTdWAGB0XUCsppzPlrGEGwjjTeeaUY9q6umjbrOUPyawDFu4SmkH0M8JWrNECMQQVxEJTl0UllIGswSUk3XBXLgNuhvQvzyqoNwKbJEpDRmkk5A2KYKRF1Gt_AXRBRl2Qf9OFhDxFAcpwhHS0XXlcQ5JTipLD1zz3FIh80WFrzaVaD4N8_-X7PxB9-zohehmJXA-q0Kp4nAF-EyJqTSj3JpRgv-1keRfVbcOVQXJIgcFrQuYJOzcqePPys3EZb4rtcp3t14GmLqqqZAl5FDR25CwHViEIXkLqiS5PWD9d6eY_PfA41M6IJtQ8_h_CekJu55Ag-sZIvkdmq19ruw8J3kofeFv-DXDsTGw priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELbK9sIFUV4NFDAICTikTWLndUCoRa0KiAWVFvVSWXZsl5W2ydLsHvrvmXGc0KAKIe1pPd7HPDwz8cw3hLySUkHeoVkowZBCbgobFixToTQph1eqtHve8WWaHZ7wT6fp6RqZ9r0wWFbZn4nuoNZNhc_IdxgEBqBL4I_fL36FODUKb1f7ERrSj1bQ7xzE2C2yDkdyGk3I-t7-9NtRfzaDdWeZb6Bjebzj5bW9aGqzjZeEOXbSXnNQDsd_OK0ni3nT3hSK_l1Rec1FHdwld3xsSXc7Zdgga6a-Rza89bb0jYeYfnufnB2bOrwCJadLVxNLZzWdzxYzTS-Gchjq5hBRD7zaUjdNnF5cgfNDpZrDHgtWgoLF7W4WH_3cQBD6gJwc7B9_OAz9oIWwgvRjGSrLZck0L2JZJToqNaK6x2Vegngt45BDSasiaY2ONbj3WCWRlTZWxhZpVUUVe0gmNbBwk9AIvKLmJo9LxRFbUIKP1EWW5lxqiCZsQMKeu2LR4WkId6mWQx7SsUmgNISXRkD2UAQDLaJhuzeay3PhjUtEsapyC7oBrpVXnEmeqChLbKoszitMAvIcBSi61tLBpsVuAcFPxjMGX_PSUSAiRo0lN-dy1bbi49cf_0H0_WhE9NoT2QZUoZK-zQH-EyJtjSi3RpRg19VoeRPVredKK_5YAOzsVfDm5RfDMn4oltHVpll1NEWa51kckEedxg6cZcAqBMcLSDHS5RHrxyv17KcDJIecGlGGysf__l1PyO0EQkJXCsm2yGR5uTJPIaRbqmfeTn8D4qlLgQ priority: 102 providerName: ProQuest |
Title | Ten-year trends in lipid management among patients after myocardial infarction in South Korea |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39361921 https://www.proquest.com/docview/3112793125 https://www.proquest.com/docview/3112857761 https://pubmed.ncbi.nlm.nih.gov/PMC11449489 https://doaj.org/article/01bc7f3129904c43a42b062f5bf93692 http://dx.doi.org/10.1371/journal.pone.0304710 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdG98ILYnytbBSDkICHVHHsfD0gtE0rA8RAY0V9QZEdx6NSl3RNK9H_njvHjQgq0qQoD_E5Ue4jdxeff0fIKykV5B2aexIMyRNFYryER8qTRSjgCJW2_zu-nEdnY_FpEk52yKZnq2NgvTW1w35S48Vs-Ptm_R4M_p3t2hCzzaThvCqLIS71xbjnateuGGExn2jXFcC67eolRi1eFPjcbab73106zspi-rdf7t58VtXbwtJ_qyv_clej--SeizPpUaMYe2SnKB-QPWfJNX3j4KbfPiQ_L4vSW4PC06Wtj6XTks6m86mm121pDLU9iagDYa2p7SxOr9fgCFHBZjDHgMWgkHG67ctHP1cQkD4i49Hp5cmZ55oueDmkIktPGSFTrkXCZB5oP9WI8M7SOAVRGy4gn5JG-dIUmmlw9UwFvpGGqcIkYZ77OX9MeiWwcJ9QHzykFkXMUiUQZ1CCPHQShbGQGiIL0yfehrvZvMHWyOwCWww5ScOmDKWROWn0yTGKoKVFZGx7oVpcZc7QMp-pPDacoZsVueBSBMqPAhMqg70Lgz55jgLMmm2mrX1nRwkEQpGIODzmpaVAdIwSy2-u5Kqus49ff9yC6PtFh-i1IzIVqEIu3ZYHeCdE3epQHnYowcbzzvA-qtuGK3XGIUyGLytEpzBzo4Lbh1-0w3hTLKkri2rV0CRhHEesT540GttylgOrECivT5KOLndY3x0pp78sODnk14g4lD69xYMPyN0AYkRbG8kPSW-5WBXPIMZbqgG5E09iOCcnDM-jDwOye3x6_u1iYP-aDKxZ_wEmFVPS |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdG9wAviPG1wGAGgYCHbPlwvh4mtMGmlm4FjQ7tBQU7jkelLilLK9R_jr-NO8cJC5oQL5P6VJ_T5ny-D_vud4S84FxA3CF9m8NGslkeKzv2Q2HzPGDwCYTU5x1Ho7B_wj6cBqcr5FdTC4NplY1O1IpalhmekW_74BiALIE9fjv7YWPXKLxdbVpocNNaQe5oiDFT2DHMlz8hhKt2Bu9hvV963sH--F3fNl0G7Ax877ktFOOJL1ns8syTTiIR0txNogTeTfkMAgiuhMNVLl0Jts0VnqO4ckWu4iDLnMyH594gqwwPUHpkdW9_9Om4sQWgTcLQFOz5kbtt5GNrVhb5Fl5KRli5e8kg6r4BrXXozaZldZXr-3cG5yWTeHCH3Da-LN2thW-NrOTFXbJmtEVFXxtI6zf3yNdxXthL4Bad6xxcOinodDKbSHrept9Q3feIGqDXiuru5fR8CcYWhXgKcxSwGwUJp-vef3RYgtN7n5xcC8sfkF4BLFwn1AErLFkeuYlgiGXIwSbLOAwixiV4L8oidsPddFbjd6T6Ei-CuKdmU4qrkZrVsMgeLkFLi-jb-ovy4iw1mzl1XJFFCmQRTDnLmM-ZJ5zQU4FQ2B_Rs8gmLmBal7K2OiTdjcHZClnow8881xSIwFFgis8ZX1RVOvj45T-IPh93iF4ZIlWCKGTclFXAOyGyV4dyo0MJeiTrDK-juDVcqdI_Ow5mNiJ49fCzdhgfiml7RV4uapo4iKLQtcjDWmJbzvrAKgTjs0jckeUO67sjxeS7BkCHGB5RjZJH__5fm-Rmf3x0mB4ORsPH5JYH7qhOw_Q3SG9-scifgDs5F0_NnqXk23Wrid9QsYpG |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJyFeEOO2wGAGgYCHrLk4t4cJbWzVSqFMY0N7QcGO41GpS8rSCvUv8qs4x3HCgibEy6Q-1Sdpc_z5XOLj7xDygnMBeYf0bQ4LyWZ5rOzYD4XN84DBJxBSv-_4OA4PTtj70-B0hfxqzsJgWWVjE7WhlmWG78j7PgQGgCXwx31lyiIO9wZvZz9s7CCFO61NOw1u2izIbU03Zg55jPLlT0jnqu3hHsz9S88b7B-_O7BNxwE7gzh8bgvFeOJLFrs886STSKQ3d5MogedUPoNkgivhcJVLV4Kfc4XnKK5ckas4yDIn8-G-N8hqBF4fEsHV3f3x4VHjF8CyhKE5vOdHbt9gZWtWFvkWblBGeIr3knPUPQRaT9GbTcvqqjD472rOS-5xcIfcNnEt3amBuEZW8uIuWTOWo6KvDb31m3vk63Fe2EvQFp3relw6Keh0MptIet6W4lDdA4ka0teK6k7m9HwJjhcBPYVrFKgbQYWX6z6AdFRCAHyfnFyLyh-QXgEqXCfUAY8sWR65iWDIa8jBP8s4DCLGJUQyyiJ2o910VnN5pHpDL4IcqFZTirORmtmwyC5OQSuLTNz6i_LiLDULO3VckUUKcAlunWXM58wTTuipQCjslehZZBMnMK2Ptbb2JN2JIfAKWejDzzzXEsjGUSCuz_iiqtLhpy__IfT5qCP0ygipEqCQcXPEAp4JWb46khsdSbApWWd4HeHWaKVK_6w-uLKB4NXDz9phvCmW8BV5uahl4iCKQtciD2vEtpr1QVVIzGeRuIPljuq7I8XkuyZDh3weGY6SR__-X5vkJpiL9MNwPHpMbnkQmeqKTH-D9OYXi_wJRJZz8dQsWUq-XbeV-A311I6K |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ten-year+trends+in+lipid+management+among+patients+after+myocardial+infarction+in+South+Korea&rft.jtitle=PloS+one&rft.au=Oh%2C+Seok&rft.au=Cho%2C+Kyung+Hoon&rft.au=Kim%2C+Min+Chul&rft.au=Sim%2C+Doo+Sun&rft.date=2024-10-03&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=19&rft.issue=10&rft.spage=e0304710&rft_id=info:doi/10.1371%2Fjournal.pone.0304710&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |